文献速递乳房整形与再造

脱细胞真皮基质在假体乳房再造中疗效的评价

Evaluation of Acellular Dermal Matrix Efficacy in Prosthesis-Based Breast Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2018-01-01

该回顾性研究比较了脱细胞真皮基质辅助与未辅助的分期假体乳房再造,发现脱细胞真皮基质组初始组织扩张器注水量显著更高(180.8 ± 150.0 vs 45.8 ± 74.4,p = 0.00),且未见注水次数和换假体时间间隔的具体数值报告,作者认为脱细胞真皮基质使用更有效。

要点

  • 脱细胞真皮基质组初始组织扩张器注水量显著高于非脱细胞真皮基质组(180.8 ± 150.0 vs 45.8 ± 74.4,p = 0.00)。
  • 校正最终假体大小后,脱细胞真皮基质组围手术期注水量显著更高(0.33 ± 0.24 vs 0.11 ± 0.16,p = 0.00)。
  • 研究期间观察到脱细胞真皮基质使用与直接置入假体再造手术呈共线趋势。

核心结论

  • 结果表明,与未使用脱细胞真皮基质的操作相比,使用脱细胞真皮基质在实现更大初始注水量、更少扩张就诊次数和更短换假体时间间隔方面更有效。

研究设计与样本

  • 经机构审查委员会批准的回顾性病历回顾,连续纳入12年期间的分期假体乳房再造病例。

主要发现

  • 脱细胞真皮基质组平均初始组织扩张器注水量显著高于非脱细胞真皮基质组(180.8 ± 150.0 vs 45.8 ± 74.4;p = 0.00)。
  • 校正最终假体大小后,脱细胞真皮基质组围手术期注水量显著更高(0.33 ± 0.24 vs 0.11 ± 0.16;p = 0.00)。
  • 研究期间观察到脱细胞真皮基质使用与直接置入假体再造手术之间呈共线趋势。

临床怎么用

  • 作者认为脱细胞真皮基质使用在实现更大初始注水量、更少扩张就诊次数和更短换假体时间间隔方面更有效。
  • 作者描述了其机构中脱细胞真皮基质使用与向直接置入假体手术过渡之间的共线关系。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although many studies have examined the safety of acellular dermal matrix in immediate prosthetic breast reconstruction, few studies have evaluated efficacy. This study examined initial tissue expander fill volume as a marker of efficacy, comparing patients after staged prosthetic breast reconstruction assisted with acellular dermal matrix versus breast reconstruction not assisted with acellular dermal matrix. Number of fill visits and time interval to implant exchange were examined as secondary endpoints. METHODS: An institutional review board-approved retrospective chart review was conducted to identify consecutive staged prosthetic reconstruction cases over 12 years. RESULTS: Mean initial tissue expander fill volume was significantly higher in the acellular dermal matrix group compared with the non-acellular dermal matrix group (180.8 ± 150.0 versus 45.8 ± 74.4; p = 0.00). Normalizing for final implant size, the acellular dermal matrix group exhibited significantly higher perioperative fill (0.33 ± 0.24 versus 0.11 ± 0.16; p = 0.00). A collinear trend was observed between acellular dermal matrix use and direct-to-implant reconstruction procedures during the study period. CONCLUSIONS: These results suggest that acellular dermal matrix use is more efficacious in achieving greater initial fill volume, fewer visits for expansion, and a shorter time interval to implant exchange compared with non-acellular dermal matrix procedures. The authors also describe a collinear relationship between acellular dermal matrix use and transition to direct-to-implant procedures at their institution. This work serves as a framework for future studies evaluating acellular dermal matrix efficacy, and guides innovation of biomaterials to support breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Sobti N, Ji E, Brown RL, et al. Evaluation of Acellular Dermal Matrix Efficacy in Prosthesis-Based Breast Reconstruction. Plast Reconstr Surg. 2018. PMID: 29481386. doi:10.1097/PRS.0000000000004109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。